ReviewDermatology and therapy2026

Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative Review.

April W Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.